These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26695373)

  • 1. The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.
    Allinson JP; Hardy R; Donaldson GC; Shaheen SO; Kuh D; Wedzicha JA
    Am J Respir Crit Care Med; 2016 Mar; 193(6):662-72. PubMed ID: 26695373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
    Stott-Miller M; Müllerová H; Miller B; Tabberer M; El Baou C; Keeley T; Martinez FJ; Han M; Dransfield M; Hansel NN; Cooper CB; Woodruff P; Ortega VE; Comellas AP; Paine Iii R; Kanner RE; Anderson W; Drummond MB; Kim V; Tal-Singer R; Lazaar AL
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2467-2476. PubMed ID: 33116463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories.
    Allinson JP; Hardy R; Donaldson GC; Shaheen SO; Kuh D; Wedzicha JA
    Am J Respir Crit Care Med; 2017 Oct; 196(8):1021-1030. PubMed ID: 28530117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH.
    Dijkstra AE; de Jong K; Boezen HM; Kromhout H; Vermeulen R; Groen HJ; Postma DS; Vonk JM
    Occup Environ Med; 2014 May; 71(5):346-52. PubMed ID: 24642640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to chronic mucus hypersecretion, a genome wide association study.
    Dijkstra AE; Smolonska J; van den Berge M; Wijmenga C; Zanen P; Luinge MA; Platteel M; Lammers JW; Dahlback M; Tosh K; Hiemstra PS; Sterk PJ; Spira A; Vestbo J; Nordestgaard BG; Benn M; Nielsen SF; Dahl M; Verschuren WM; Picavet HS; Smit HA; Owsijewitsch M; Kauczor HU; de Koning HJ; Nizankowska-Mogilnicka E; Mejza F; Nastalek P; van Diemen CC; Cho MH; Silverman EK; Crapo JD; Beaty TH; Lomas DA; Bakke P; Gulsvik A; Bossé Y; Obeidat M; Loth DW; Lahousse L; Rivadeneira F; Uitterlinden AG; Hofman A; Stricker BH; Brusselle GG; van Duijn CM; Brouwer U; Koppelman GH; Vonk JM; Nawijn MC; Groen HJ; Timens W; Boezen HM; Postma DS;
    PLoS One; 2014; 9(4):e91621. PubMed ID: 24714607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic mucus hypersecretion: a marker of asthma in young adults?
    Ulrik CS; von Linstow ML; Nepper-Christensen S; Porsbjerg C; Backer V
    Respir Med; 2005 Dec; 99(12):1576-82. PubMed ID: 16291078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic mucus hypersecretion: prevalence and risk factors in younger individuals.
    Harmsen L; Thomsen SF; Ingebrigtsen T; Steffensen IE; Skadhauge LR; Kyvik KO; Backer V
    Int J Tuberc Lung Dis; 2010 Aug; 14(8):1052-8. PubMed ID: 20626952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease.
    Kim V; Zhao H; Boriek AM; Anzueto A; Soler X; Bhatt SP; Rennard SI; Wise R; Comellas A; Ramsdell JW; Kinney GL; Han MK; Martinez CH; Yen A; Black-Shinn J; Porszasz J; Criner GJ; Hanania NA; Sharafkhaneh A; Crapo JD; Make BJ; Silverman EK; Curtis JL;
    Ann Am Thorac Soc; 2016 Jul; 13(7):1016-25. PubMed ID: 27158740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Mucus Hypersecretion and the Natural History of Chronic Obstructive Pulmonary Disease.
    Lange P; Vestbo J
    Am J Respir Crit Care Med; 2016 Mar; 193(6):602-3. PubMed ID: 26977967
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD.
    Dijkstra AE; Boezen HM; van den Berge M; Vonk JM; Hiemstra PS; Barr RG; Burkart KM; Manichaikul A; Pottinger TD; Silverman EK; Cho MH; Crapo JD; Beaty TH; Bakke P; Gulsvik A; Lomas DA; Bossé Y; Nickle DC; Paré PD; de Koning HJ; Lammers JW; Zanen P; Smolonska J; Wijmenga C; Brandsma CA; Groen HJ; Postma DS;
    Eur Respir J; 2015 Jan; 45(1):60-75. PubMed ID: 25234806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study.
    Toren K; Schiöler L; Lindberg A; Andersson A; Behndig AF; Bergström G; Blomberg A; Caidahl K; Engvall J; Eriksson M; Hamrefors V; Janson C; Kylhammar D; Lindberg E; Lindén A; Malinovschi A; Persson HL; Sandelin M; Eriksson Ström J; Tanash HA; Vikgren J; Östgren CJ; Wollmer P; Sköld CM
    BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32759170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.
    Donovan LM; Rise PJ; Carson SS; Feemster LC; Griffith MF; Kapur VK; Krishnan JA; Lindenauer PK; Mularski RA; Naureckas ET; Palen BN; Parsons EC; Spece LJ; Vitiello MV; Au DH;
    Ann Am Thorac Soc; 2017 Dec; 14(12):1836-1843. PubMed ID: 28825846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
    Maestrelli P; Saetta M; Mapp CE; Fabbri LM
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment.
    Shah BK; Singh B; Wang Y; Xie S; Wang C
    Mediators Inflamm; 2023; 2023():8840594. PubMed ID: 37457746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.